Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes
Crossref DOI link: https://doi.org/10.1007/s11739-017-1688-7
Published Online: 2017-06-24
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Imberti, Davide
Mastroiacovo, Daniela
License valid from 2017-06-24